文献速递慢性肾脏病

减重手术对慢性肾脏病风险的影响

Effect of Bariatric Surgery on CKD Risk.
PubMed 文献 · J Am Soc Nephrol · 2018-01-15

该研究纳入2144例接受减重手术的成人,随访7年,采用KDIGO标准评估CKD风险。结果显示,基线中、高、极高危患者术后1年和7年CKD风险均改善,风险恶化比例≤10%,5例进展为ESRD。

要点

  • 减重手术可改善中高危CKD患者的风险分层,持续至术后7年。
  • 术后CKD风险恶化比例不超过10%,ESRD发生少见。
  • 评估减重手术时应考虑CKD风险,高危肥胖CKD患者或可受益。

核心结论

  • 减重手术与大部分患者CKD风险类别改善相关,尤其基线中危和高危者,效果持续至7年。

研究设计与样本

  • 研究纳入2006年3月至2009年4月接受减重手术并参与LABS-2队列的2144例成人,随访7年。

主要发现

  • 基线中危患者术后1年和7年CKD风险改善比例分别为63%和53%。
  • 基线高危患者术后1年和7年CKD风险改善比例分别为78%和56%。
  • 基线极高危患者术后1年和7年CKD风险改善比例分别为59%和23%。
  • CKD风险恶化比例≤10%,5例患者进展为ESRD。
  • 以术后1年为基线的敏感性分析及不同eGFR公式结果定性相似。

关键数值与推荐

  • CKD风险采用KDIGO共识标准,结合eGFR和白蛋白尿评估。

临床怎么用

  • 在减重手术评估中应纳入CKD风险评估。
  • 对高危肥胖CKD患者,减重手术可作为潜在治疗选择进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Obesity is linked to the development and progression of CKD, but whether bariatric surgery protects against CKD is poorly understood. We, therefore, examined whether bariatric surgery influences CKD risk. The study included 2144 adults who underwent bariatric surgery from March of 2006 to April of 2009 and participated in the Longitudinal Assessment of Bariatric Surgery-2 Study cohort. The primary outcome was CKD risk categories as assessed by the Kidney Disease Improving Global Outcomes (KDIGO) consortium criteria using a combination of eGFR and albuminuria. Patients were 79% women and 87% white, with a median age of 46 years old. Improvements were observed in CKD risk at 1 and 7 years after surgery in patients with moderate baseline CKD risk (63% and 53%, respectively), high baseline risk (78% and 56%, respectively), and very high baseline risk (59% and 23%, respectively). The proportion of patients whose CKD risk worsened was ≤10%; five patients developed ESRD. Sensitivity analyses using year 1 as baseline to minimize the effect of weight loss on serum creatinine and differing eGFR equations offered qualitatively similar results. Treatment with bariatric surgery associated with an improvement in CKD risk categories in a large proportion of patients for up to 7 years, especially in those with moderate and high baseline risk. These findings support consideration of CKD risk in evaluation for bariatric surgery and further study of bariatric surgery as a treatment for high-risk obese patients with CKD.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Friedman AN, Wahed AS, Wang J, et al. Effect of Bariatric Surgery on CKD Risk. J Am Soc Nephrol. 2018. PMID: 29335242. doi:10.1681/ASN.2017060707

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。